The ability of miR-100 to attenuate lamellipodia formation, matrix metallopeptidase 2 (MMP2) activation and metastasis in hepatocellular carcinoma cells was associated to ICMT-RAC1 signaling inhibition (79). Here, MMP2 is linked to hepatocellular carcinoma.